Atrial Fibrillation Flashcards
hallmark of AF
irregularly irregular pulse
absent P waves on ECG
differential for an irregularly irregular pulse
ventricular ectopics
symptoms of AF
usually asymptomatic
symptoms can include
- palpitations
- SOB
- syncope
- complications e.g. stroke
underlying causes of AF
Sepsis
Mitral valve stenosis
Ischaemic heart disease
Thyrotoxicosis
HTN
How can AF be classified
first detected episode
paroxysmal
persistent
permanent
what is paroxysmal AF
AF that self terminates episodes last <7 days (typically less than 24 hours)
what is persistent AF
AF that does not self terminate - requires cardio version episodes last > 7 days
what is permanent AF
AF that cannot be cardioverted - goal is rate control + decrease stroke risk
1st line rate control in patients with no contraindications
beta blocker e.g. atenolol
contraindication to atenolol
asthma
2nd line options for rate control
diltiazem - rate limiting ca channel blocker (avoid in HF)
digoxin - good in HF
what patients would be suitable for rhythm control
episode of AF < 48 hours
reversible cause of their AF
AF is causing HF
symptomatic
two methods of cardioversion
pharmacological e.g. flecanide / amiodarone
electrical - DC cardioversion
amiodarone is used for cardioversion in which patients
patients with structural heart disease
what patients are suitable for immediate cardioversion
AF present for < 48 hours
haemodynamically unstable
what patients receive delayed cardioversion
AF present > 48 hours
stable
what is required before delayed cardioversion
3 weeks anticoagulation
score used to calculate anticocoagulation requirement in AF patients
CHA2DS2-VASC
what does CHA2DS2-VASc stand for
Congestive HF = 1 point
HTN = 1 point
Age2 > 75 = 2 points
Diabetes = 1 point
Stroke / Tia previously = 2 points
Vascular disease = 1 point
Age 65-74 = 1 point
Sex (female) = 1 point
what CHA2DS2-VASC score should be offered anticoagulation
>1
anticoagulation options for AF
Warfarin - vitamin K antagonist (Aim for INR 2-3)
Rivaroxaban / Apixaban - factor Xa inhibitors